KRIS TREANOR, M.S.

Kris Treanor brings 20 years of combined experience in the healthcare industry. She began her career at ZS Associates, a global consulting firm, where she spent 6 years solving a variety of complex business problems, all with the underlying goal of advancing healthcare. Since then, Kris has held roles of increasing scope and responsibilities at a number of biopharma companies, providing insights and contributing to key strategic decisions.

Prior to joining Sutro in 2022, she spent over 3 years at BeiGene, where she was integral in planning the commercial strategy and launch success of zanubrutinib in Mantle Cell Lymphoma and subsequent indications. At Sutro, Kris leads commercial strategy and new product planning.

She received her Sc. B. in Biology at Brown University and her M.S. in Microbiology & Immunology at Stanford University.